You are on page 1of 4

This site is intended for healthcare professionals

Edition: ENGLISH DEUTSCH ESPAOL FRANAIS PORTUGUS


Register Log In

NEWS & PERSPECTIVE DRUGS & DISEASES CME &


EDUCATION ACADEMY VIDEO NEW
Drugs & Diseases > Dermatology

Irritant Contact Dermatitis


Updated: Jul 26, 2017
Author: Savina Aneja, MD; Chief Editor: William D James, MD more...

Practice Essentials
Contact dermatitis is an acute or chronic skin inammation caused by cutaneous
interaction with a chemical, biologic, or physical agent. Contact dermatitis after a
single exposure or multiple exposures may be irritant or allergenicclinically it
may be difficult to differentiate between these processes. Irritant contact dermatitis
(ICD) is caused by direct tissue damage following a single exposure or multiple
exposures to a known irritant. By contrast, in allergic contact dermatitis, tissue
damage by allergic substances is mediated through immunologic mechanisms. A
complete history related to exposures at home, the workplace, and in recreational
activities is essential to making the diagnosis and identifying the causative agent.
Acutely, eczematous or nonspecific dermatitis is the most common clinical
expression of this induced inammation. The severity of the dermatitis ranges from
a mild, short-lived condition to a severe, persistent, job-threatening, and possibly
life-threatening disease. Treatment of both irritant contact dermatitis and allergic
contact dermatitis begins with removal of the offending substance(s).
The American Academy of Allergy, Asthma & Immunology and the American
College of Allergy, Asthma & Immunology published updated clinical practice
guidelines on contact dermatitis in 2015. [1] Recommendations pertaining
specifically to irritant contact dermatitis are briefly summarized in the Guidelines
section.
Next: Background

What to Read Next on Medscape

Related Conditions and Diseases


Dermatitis Herpetiformis
Stasis Dermatitis

Seborrheic Dermatitis

Berloque Dermatitis

Exfoliative Dermatitis

Diaper Dermatitis
NEWS & PERSPECTIVE

EU Approves Dupilumab (Dupixent) for Atopic


Dermatitis

Lilly/Incyte Pill Beats Placebo in Mid-stage Eczema Trial


Moisturizers Labeled 'Hypoallergenic' May Still Have Toxic Chemicals
TOOLS

Drug Interaction Checker


Pill Identifier
Calculators
Formulary
SLIDESHOW

Contact Dermatitis: An Overview


Most Popular Articles
According to Allergist / Immunologists
1. Allergists Respond to Death of Boy, 3, in Food Challenge

2. Peanut Allergy: Is Oral Immunotherapy With Probiotic a Cure?


3. Thunderstorm Asthma on the Rise
4. Use of Biologics in Severe Food Allergies
5. Aspirin Challenge and Desensitization: How, When and Why
View More

Overview
o Practice Essentials
o Background

o Pathophysiology

o Etiology

o Epidemiology

o Prognosis

o Patient Education

o Show All
Presentation
DDx
Workup
Treatment
Guidelines
Medication
References

Recommended
DISEASES & CONDITIONS Dermatitis Herpetiformis

DISEASES & CONDITIONS Stasis Dermatitis

FIND US ON

ABOUT

About MedscapePrivacy PolicyTerms of UseAdvertising PolicyHelp Center


MEMBERSHIP

Become a MemberEmail NewslettersManage My Account


APPS

MedscapeMedPulse NewsCME & Education


WEBMD NETWORK

WebMDMedicineNeteMedicineHealthRxListWebMD Corporate
EDITIONS

EnglishDeutschEspaolFranaisPortugus
All material on this website is protected by copyright, Copyright 1994-2017 by
WebMD LLC. This website also contains material copyrighted by 3rd parties.

Medscape VIDEO NEW Clinical. Captivating. Award-Winning. Explore Now

You might also like